159 related articles for article (PubMed ID: 38604404)
1. Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea.
Moon JY; Kim SH; Kim Y; Lee H; Rhee CK; Ra SW; Lee CY; Park JH; Park YB; Yoo KH
Pulm Pharmacol Ther; 2024 Jun; 85():102298. PubMed ID: 38604404
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.
Harb HS; Laz NI; Rabea H; Abdelrahim MEA
Eur J Pharm Sci; 2020 Apr; 147():105298. PubMed ID: 32151707
[TBL] [Abstract][Full Text] [Related]
4. Determinants of Suboptimal Peak Inspiratory Flow Rates among Patients with Chronic Obstructive Pulmonary Disease in Southwest, Nigeria.
Arawomo AO; Erhabor GE; Tanimowo MO; Awopeju OF; Adewole OO; Adeniyi BO; Afolabi BA; Ekundayo MW
West Afr J Med; 2023 May; 40(5):553-561. PubMed ID: 37247343
[TBL] [Abstract][Full Text] [Related]
5. Inappropriate Peak Inspiratory Flow Rate in the Patients with Stable Chronic Obstructive Pulmonary Disease in Korea.
Youn SH; Kim HJ; Park JS; Park SH; Kwon YS; Kim MA
Tuberc Respir Dis (Seoul); 2024 Apr; ():. PubMed ID: 38659389
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler.
Mahler DA; Waterman LA; Gifford AH
J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):174-9. PubMed ID: 23025451
[TBL] [Abstract][Full Text] [Related]
7. Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.
Ghosh S; Ohar JA; Drummond MB
J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):381-387. PubMed ID: 28933581
[TBL] [Abstract][Full Text] [Related]
8. Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma.
Hua JL; Ye XF; Du CL; Xie N; Zhang JQ; Li M; Zhang J
BMC Pulm Med; 2021 Sep; 21(1):302. PubMed ID: 34560863
[TBL] [Abstract][Full Text] [Related]
9. Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases.
Meng W; Xiong R; Zhao Z; Zeng H; Chen Y
BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38642917
[TBL] [Abstract][Full Text] [Related]
10. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
[TBL] [Abstract][Full Text] [Related]
11. Association between peak inspiratory flow rate and hand grip muscle strength in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease.
Samarghandi A; Ioachimescu OC; Qayyum R
PLoS One; 2020; 15(1):e0227737. PubMed ID: 32004333
[TBL] [Abstract][Full Text] [Related]
12. Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD.
Duarte AG; Tung L; Zhang W; Hsu ES; Kuo YF; Sharma G
Chronic Obstr Pulm Dis; 2019 Jul; 6(3):246-255. PubMed ID: 31189057
[TBL] [Abstract][Full Text] [Related]
13. Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases.
Kawamatawong T; Khiawwan S; Pornsuriyasak P
J Asthma Allergy; 2017; 10():17-21. PubMed ID: 28260934
[TBL] [Abstract][Full Text] [Related]
14. Aerosol drug-delivery and short-term clinical outcomes of suboptimal peak inspiratory flow rate in chronic obstructive pulmonary disease.
Harb HS; Ibrahim Laz N; Rabea H; Madney YM; Boshra MS; Abdelrahim MEA
Int J Clin Pract; 2021 Dec; 75(12):e14845. PubMed ID: 34519141
[TBL] [Abstract][Full Text] [Related]
15. Getting the Most out of Spirometry: A Tool to Guide Dry Powder Inhaler Use.
Hanon S; Vanderhelst E; Buls N; Verbanck S
Respiration; 2022; 101(10):893-900. PubMed ID: 36030775
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
Mahler DA; Waterman LA; Ward J; Gifford AH
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
[TBL] [Abstract][Full Text] [Related]
17. Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease.
Chen SY; Huang CK; Peng HC; Yu CJ; Chien JY
Sci Rep; 2020 Apr; 10(1):7271. PubMed ID: 32350352
[TBL] [Abstract][Full Text] [Related]
18. Peak Inspiratory Flow Measured at Different Inhaler Resistances in Patients with Asthma.
Haughney J; Lee AJ; McKnight E; Pertsovskaya I; O'Driscoll M; Usmani OS
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):890-896. PubMed ID: 33011302
[TBL] [Abstract][Full Text] [Related]
19. Can patients achieve sufficient peak inspiratory flow rate (PIFR) with Turbuhaler® during acute exacerbation of asthma?
Mohd Rhazi NA; Muneswarao J; Abdul Aziz F; Ibrahim B; Kamalludin A; Soelar SA
J Asthma; 2023 Aug; 60(8):1608-1612. PubMed ID: 36650693
[TBL] [Abstract][Full Text] [Related]
20. Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial.
Hua J; Zhang W; Cao HF; Du CL; Ma JY; Zuo YH; Zhang J
BMJ Open; 2020 May; 10(5):e034804. PubMed ID: 32385061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
